+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dynavax Technologies Corporation - logo

Dynavax is a clinical-stage biopharmaceutical company with multiple product candidates in development for the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. The company’s lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine; and AZD1419, which is in Phase II clinical trial for the treatment of asthma. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.

Angina Pectoris Drugs Market Report 2025 - Product Thumbnail Image

Angina Pectoris Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Myocardial Infarction Market Report 2025 - Product Thumbnail Image

Myocardial Infarction Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Autologous Cell Therapy Market Report 2025 - Product Thumbnail Image

Autologous Cell Therapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
Loading Indicator